Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of the treatment of neurological diseases to patients worldwide. From Wikipedia
The decision overturns an initial rejection, confirming the drug's efficacy in slowing cognitive decline while addressing safety concerns.
